MedTrace Logo

Heliox in Preterm Infants With Respiratory Distress Syndrome

NCT01759316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2013-10-28

No results posted yet for this study

Summary

Heliox can lower respiratory resistance, improve the oxygenation, reduce respiratory distress and lung injury caused by mechanical ventilation.

Conditions

  • Respiratory Distress Syndrome

Interventions

OTHER

heliox

heliox or oxygen is used in the two groups respectively

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Yuan Shi, MD, PhD · Dpartment of Pediatrics, Daping Hospital, Third Military Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
28 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759316 on ClinicalTrials.gov